Literature DB >> 2806989

Comparison of IgA-class reticulin and endomysium antibodies in coeliac disease and dermatitis herpetiformis.

O Hällström1.   

Abstract

The occurrence of IgA class reticulin and endomysium antibodies was examined with the standard immunofluorescence method in coeliac disease and dermatitis herpetiformis. Similar high antibody frequencies were detected in 32 untreated adults (91%) and 18 children (100%) with coeliac disease and in 14 dermatitis herpetiformis patients with subtotal villous atrophy (reticulin antibodies 93% and endomysium antibodies 100%). The specificity of IgA class reticulin antibodies and endomysium antibodies was high because all 45 adult patients with ulcerative colitis or Crohn's disease, 24 non-coeliac children with abdominal symptoms and 99/100 healthy blood donors were negative for these antibodies. The only positive blood donor had both IgA class reticulin antibodies and endomysium antibodies but also she was found to have coeliac disease. IgA class reticulin antibodies and endomysium antibodies declined in parallel during treatment with a gluten free diet and increased on gluten challenge. This suggests that these antibodies can be used to screen for gluten sensitive enteropathy and to monitor dietary treatment. To characterise the tissue specificity of reticulin antibodies and endomysium antibodies four positive sera were absorbed with human and several rodent liver homogenates. Absorption with rat or other rodent livers removed the rodent-specific reticulin antibodies but not the reticulin antibodies detectable with human tissues or the endomysium antibodies detectable with monkey oesophagus. These results show that reticulin antibodies can be divided into the rat and human subtypes. The human subtype could not be separated from endomysium antibodies in the present absorption experiments.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2806989      PMCID: PMC1434235          DOI: 10.1136/gut.30.9.1225

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  29 in total

1.  IgA class reticulin antibodies in relatives of patients with coeliac disease.

Authors:  E G Mallas; N Williamson; B T Cooper; W T Cooke
Journal:  Gut       Date:  1977-08       Impact factor: 23.059

2.  Anticonnective tissue and other antitissue 'antibodies' in the sera of patients with coeliac disease compared with the findings in a mixed hospital population.

Authors:  N Williamson; P Asquith; L Stokes; W Jowett; W T Cooke
Journal:  J Clin Pathol       Date:  1976-06       Impact factor: 3.411

3.  Antireticulin antibody: incidence and diagnostic significance.

Authors:  P P Seah; L Fry; E J Holborow; M A Rossiter; W F Doe; A F Magalhaes; A V Hoffbrand
Journal:  Gut       Date:  1973-04       Impact factor: 23.059

4.  Types of 'reticulin' antibodies detected in human sera by immunofluorescence.

Authors:  M Rizzetto; D Doniach
Journal:  J Clin Pathol       Date:  1973-11       Impact factor: 3.411

5.  Anti-reticulin antibodies in childhood coeliac disease.

Authors:  P P Seah; L Fry; M A Rossiter; A V Hoffbrand; E J Holborow
Journal:  Lancet       Date:  1971-09-25       Impact factor: 79.321

6.  Autoantibodies to reticulin in patients with idiopathic steatorrhoea, coeliac disease, and Crohn's disease, and their relation to immunoglobulins and dietary antibodies.

Authors:  M H Alp; R Wright
Journal:  Lancet       Date:  1971-09-25       Impact factor: 79.321

7.  Tissue antibodies in dermatitis herpetiformis and adult coeliac disease.

Authors:  P P Seah; L Fry; A V Hoffbrand; E J Holborow
Journal:  Lancet       Date:  1971-04-24       Impact factor: 79.321

8.  Anti-reticulin antibodies: useful adjunct to histopathology in diagnosing celiac disease, especially in a developing country.

Authors:  V Khoshoo; M K Bhan; D J Unsworth; R Kumar; J A Walker Smith
Journal:  J Pediatr Gastroenterol Nutr       Date:  1988 Nov-Dec       Impact factor: 2.839

9.  Reticulin antibodies in patients with coeliac disease and their relatives.

Authors:  F M Stevens; R Lloyd; B Egan-Mitchell; M J Mylotte; P F Fottrell; R Wright; B McNicholl; C F McCarthy
Journal:  Gut       Date:  1975-08       Impact factor: 23.059

10.  Studies on the nature and significance of connective tissue antibodies in adult coeliac disease and Crohn's disease.

Authors:  A F Magalhaes; T J Peters; W F Doe
Journal:  Gut       Date:  1974-04       Impact factor: 23.059

View more
  23 in total

1.  Local challenge of oral mucosa with gliadin in patients with coeliac disease.

Authors:  H Lähteenoja; M Mäki; M Viander; A Toivanen; S Syrjänen
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

2.  Serologic testing for celiac disease in the United States: results of a multilaboratory comparison study.

Authors:  J A Murray; J Herlein; F Mitros; J A Goeken
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

Review 3.  Endomysial antibody in the diagnosis and management of coeliac disease.

Authors:  M W James; B B Scott
Journal:  Postgrad Med J       Date:  2000-08       Impact factor: 2.401

4.  B cell epitopes of gliadin.

Authors:  A A Osman; T Günnel; A Dietl; H H Uhlig; M Amin; B Fleckenstein; T Richter; T Mothes
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

5.  IgA antiendomysial antibody test. A step forward in celiac disease screening.

Authors:  U Volta; N Molinaro; M Fusconi; F Cassani; F B Bianchi
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

6.  ACP Broadsheet No 149: September 1996. Serological diagnosis of gluten sensitive enteropathy.

Authors:  D J Unsworth
Journal:  J Clin Pathol       Date:  1996-09       Impact factor: 3.411

Review 7.  Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.

Authors:  Stefania Martucciello; Gaetana Paolella; Carla Esposito; Marilena Lepretti; Ivana Caputo
Journal:  Cell Mol Life Sci       Date:  2018-08-22       Impact factor: 9.261

8.  Ultrastructural binding sites of endomysium antibodies from sera of patients with dermatitis herpetiformis and coeliac disease.

Authors:  S Kárpáti; M Meurer; W Stolz; A Bürgin-Wolff; O Braun-Falco; T Krieg
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

9.  IgA anti-endomysial antibodies on human umbilical cord tissue for celiac disease screening. Save both money and monkeys.

Authors:  U Volta; N Molinaro; L de Franceschi; D Fratangelo; F B Bianchi
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

10.  IgA antibodies to jejunum. Specific immunity directed against target organ of gluten-sensitive enteropathy.

Authors:  U Volta; N Molinaro; D Fratangelo; F B Bianchi
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.